(S)-N-(3,4-dimethoxybenzyl)-1-(2-((1-(piperidin-4-yl)-1H-pyrazol-4-yl)amino)pyridin-4-yl)piperidine-3-carboxamide

ID: ALA4459539

PubChem CID: 155527557

Max Phase: Preclinical

Molecular Formula: C28H37N7O3

Molecular Weight: 519.65

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc(CNC(=O)[C@H]2CCCN(c3ccnc(Nc4cnn(C5CCNCC5)c4)c3)C2)cc1OC

Standard InChI:  InChI=1S/C28H37N7O3/c1-37-25-6-5-20(14-26(25)38-2)16-31-28(36)21-4-3-13-34(18-21)24-9-12-30-27(15-24)33-22-17-32-35(19-22)23-7-10-29-11-8-23/h5-6,9,12,14-15,17,19,21,23,29H,3-4,7-8,10-11,13,16,18H2,1-2H3,(H,30,33)(H,31,36)/t21-/m0/s1

Standard InChI Key:  ABRGHUZQRYFTGF-NRFANRHFSA-N

Molfile:  

 
     RDKit          2D

 38 42  0  0  0  0  0  0  0  0999 V2000
   20.3101  -11.8617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3101  -12.6830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0195  -13.0916    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.7289  -12.6830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7289  -11.8617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0195  -11.4489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0191  -13.9121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3056  -14.3200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3053  -15.1406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0176  -15.5541    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.7318  -15.1370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7287  -14.3178    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4419  -11.4551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1526  -11.8658    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.4443  -10.6338    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.8656  -11.4593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5762  -11.8699    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5725  -12.6923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2782  -13.1070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9922  -12.6963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9920  -11.8708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2816  -11.4639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5932  -15.5530    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.8850  -15.1453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7960  -14.3362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9964  -14.1674    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.5888  -14.8757    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.1365  -15.4822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6630  -13.4213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1472  -12.7613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8170  -12.0176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0043  -11.9291    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.5227  -12.5905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8539  -13.3404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6989  -11.4608    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.4074  -11.8681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6996  -13.1054    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.6991  -13.9226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  3  7  1  0
  5 13  1  6
 13 14  1  0
 13 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
  9 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 28 24  1  0
 26 29  1  0
 29 30  1  0
 29 34  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 21 35  1  0
 35 36  1  0
 20 37  1  0
 37 38  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4459539

    ---

Associated Targets(Human)

ROS1 Tclin Proto-oncogene tyrosine-protein kinase ROS (2436 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALK Tclin ALK tyrosine kinase receptor (7132 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H3122 (436 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCC78 (247 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 519.65Molecular Weight (Monoisotopic): 519.2958AlogP: 3.50#Rotatable Bonds: 9
Polar Surface Area: 105.57Molecular Species: BASEHBA: 9HBD: 3
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 10.12CX LogP: 2.02CX LogD: -1.64
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.39Np Likeness Score: -1.35

References

1. Liu S, Jiang Y, Yan R, Li Z, Wan S, Zhang T, Wu X, Hou J, Zhu Z, Tian Y, Zhang J..  (2019)  Design, synthesis and biological evaluations of 2-amino-4-(1-piperidine) pyridine derivatives as novel anti crizotinib-resistant ALK/ROS1 dual inhibitors.,  179  [PMID:31260890] [10.1016/j.ejmech.2019.06.043]

Source